BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 6:27:00 PM | Browse: 1121 | Download: 1295
 |
Received |
|
2013-11-12 13:50 |
|
Peer-Review Started |
|
2013-11-13 10:20 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2013-12-17 17:23 |
|
Revised |
|
2013-12-19 22:17 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-03-18 14:59 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2014-03-18 15:22 |
|
Articles in Press |
|
|
|
Edit the Manuscript by Language Editor |
|
2014-04-02 23:50 |
|
Typeset the Manuscript |
|
2014-04-20 17:00 |
|
Publish the Manuscript Online |
|
2014-04-28 14:14 |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Topic Highlights |
| Article Title |
Mesenchymal stem cells in treating autism: Novel insights
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Dario Siniscalco, James Jeffrey Bradstreet, Nataliia Sych and Nicola Antonucci |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dario Siniscalco, ChemD, PhD, Department of Experimental Medicine, Second University of Naples, Via S Maria di Costantinopoli, 16-80138 Napoli, Italy. dariosin@uab.edu |
| Key Words |
Autism spectrum disorders; Autism treatment; Cell therapy; Mesenchymal stem cells |
| Core Tip |
Autism spectrum disorders are still untreatable pathologies. Mesenchymal stem cells possess the immunological properties which make them promising candidates as a novel therapeutic option. |
| Publish Date |
2014-04-28 14:14 |
| Citation |
Siniscalco D, Bradstreet JJ, Sych N, Antonucci N. Mesenchymal stem cells in treating autism: Novel insights. World J Stem Cells 2014; 6(2): 173-178
|
| URL |
http://www.wjgnet.com/1948-0210/full/v6/i2/173.htm |
| DOI |
http://dx.doi.org/10.4252/wjsc.v6.i2.173 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
